notes

20200718144852-feminizing_hormone_therapy.org

@@ -18,6 +18,10 @@ stimulation. It appears more likely that any reduction in sexual function
 experienced during HRT is due to lowered interest and atrophy ([[file:CBettocchi1969.org][Bettocchi et al.,
 2004]]).
 
+Distress due to lowered sexual interest meets the critera for hypoactive sexual
+desire disorder. Maintenance of erectile function may benefit from low-dose
+testosterone or PDE5 inhibitors ([[file:MatsHolmberg1970.org][Holmberg et al., 2018]]).
+
 * Is Progesterone an important addition to a feminizing HRT regimen?
 The addition of progesterone may yield improved feminization and breast
 development in transgender women ([[file:JerilynnCPrior1968.org][Prior, 2019]]).
@@ -25,3 +29,10 @@ development in transgender women ([[file:JerilynnCPrior1968.org][Prior, 2019]]).
 * References
 - [[file:PrimaryAuthorDr.AmyBournsMDCCFP1963.org][Guidelines for gender-affirming primary care with trans and non-binary
   patients]], from Sherbourne Health in Ontario, 2019.
+- [[file:MadelineB.DeutschMDMPH1974.org][Guidelines for the primary and gender-affirming care of transgender and gender
+  nonbinary people (second edition)]], from the University of California, San
+  Francisco, 2016.
+- [[file:MatsHolmberg1970.org][Supporting sexuality and improving sexual function in transgender persons]],
+  Nature Reviews Urology, Sweden, 2018.
+- [[file:JerilynnCPrior1968.org][Progesterone is important for transgender women’s therapy—applying evidence
+  for the benefits of progesterone in ciswomen]], Endocrine Society, 2019.

AndreaM.Isidori1976.org

@@ -0,0 +1,3 @@
+#+TITLE: A critical analysis of the role of testosterone in erectile function: from pathophysiology to treatment—a systematic review
+#+ROAM_KEY: cite:AndreaM.Isidori1977
+#+ROAM_ALIAS: "Isidori et al., 2013"

MadelineB.DeutschMDMPH1974.org

@@ -0,0 +1,2 @@
+#+TITLE: Guidelines for the primary and gender-affirming care of transgender and gender nonbinary people (second edition)
+#+ROAM_KEY: cite:MadelineB.DeutschMDMPH1974

MatsHolmberg1970.org

@@ -0,0 +1,18 @@
+#+TITLE: Supporting sexuality and improving sexual function in transgender persons
+#+ROAM_KEY: cite:MatsHolmberg1970
+#+ROAM_ALIAS: "Holmberg et al., 2018"
+
+* Excerpts
+
+#+begin_quote
+For some transgender women, low sexual desire can lead to personal or relational
+distress, fulfilling the diagnostic criteria for hypoactive sexual desire
+disorder (HSDD).
+#+end_quote
+
+#+begin_quote
+For transgender women who wish to maintain erectile ability, occurrence of
+nocturnal and spontaneous erections might, therefore, be important, and can be
+supported by low-​dose testosterone and/or the use of phosphodiesterase type 5
+(PDE5) inhibitors. ([[file:AndreaM.Isidori1976.org][Isidori et al., 2013]])
+#+end_quote